mTOR Targeted Cancer Chemoprevention by Flavonoids

Area of Science:

• Biochemistry
• Molecular Biology
• Pharmacology

Background:

• Plant-derived phytochemicals, particularly flavonoids, exhibit significant therapeutic potential, especially in cancer treatment.
• Flavonoids exert anticancer effects by modulating critical cell signaling pathways.
• The phosphatidyl-inositol 3-kinase (PI3K)/protein kinase B (Akt)/mammalian target of rapamycin (mTOR) cascade is a key regulator of cell survival and proliferation, making it a prime target for cancer therapy.

Purpose of the Study:

• To investigate the anticancer potential of various flavonoids, focusing on flavones, flavonols, and isoflavones.
• To specifically examine the role of these flavonoids in targeting the PI3K/Akt/mTOR signaling pathway.
• To evaluate specific compounds including apigenin, luteolin, baicalein, tangeretin, epigallocatechin-3-gallate, genistein, and daidzein.

Main Methods:

• Literature review on flavonoid anticancer activity and mTOR targeting.
• Analysis of signaling pathway modulation by selected flavonoids.
• Focus on the PI3K/Akt/mTOR cascade's role in cancer cell apoptosis and proliferation.

Main Results:

• Flavonoids, including flavones, flavonols, and isoflavones, demonstrate potent anticancer activities.
• These compounds effectively modulate the PI3K/Akt/mTOR signaling pathway.
• Specific flavonoids like apigenin, genistein, and epigallocatechin-3-gallate show promise in targeting this critical cancer pathway.

Conclusions:

• Flavonoids represent a promising class of natural compounds for cancer therapy.
• Targeting the PI3K/Akt/mTOR pathway with flavonoids offers a viable strategy to inhibit cancer cell proliferation and induce apoptosis.
• Further research into specific flavonoids and their mechanisms is warranted for drug development.